TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2026
Neoadjuvant Intralesional Daromun (L19IL2/L19TNF) in Resectable Locally Advanced Melanoma: An Update on the Efficacy and Safety Results of the PIVOTAL Phase III Trial.
Axel Hauschild et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.